Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center

A Pilot and Feasibility Neoadjuvant Study of a 2-Week Ketogenic Diet in Combination with Letrozole to Modulate PI3K Signaling in ER+ Breast Cancer

Not Available
Early I
Rexer, Brent

DS-8201a Versus T-DM1 for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive, Unresectable and / or Metastatic Breast Cancer Previously Treated With Trastuzumab and Taxane [DESTINY-Breast03]

This study is designed to compare the anti-tumor activity as well as the safety and efficacy of DS-8201a versus T-DM1 in HER2-positive, unresectable and / or metastatic breast cancer subjects previously treated with trastuzumab and taxane.
Not Available
Rexer, Brent

To learn more about any of our clinical
trials, call 1-800-811-8480 or complete
the online Self-Referral Form here: